This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

HENRY E. MICHELSON, M.D.; RICHARD J. STEVES, M.D.

Arch Derm Syphilol. 1947;56(3):317-324.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

DURING the last two years numerous reports have appeared in the European literature concerning the use of vitamin D in the treatment of cutaneous tuberculosis. Investigators in Belgium, France and England independently investigated the oral administration of large doses of vitamin D₂.

In the years which followed the announcement by Steenbock and his colleagues¹ of an antirachitic substance in irradiated sterols, Malmström, Villaret, Justin-Besançon and Fauvert, Bergmann² and others discovered that these new forms of vitamin D were useful in the treatment of various types of tuberculosis.

In 1930 Levaditi and Po and Spies³ reported that experimental tuberculosis in rabbits was distinctly benefited by the administration of large doses of irradiated ergosterol. These investigators observed that tuberculous tissue had a selective tendency to become calcified under the influence of this substance. A mineral shell formed around the areas of necrosis, and within this shell the tubercle . . . [Full Text PDF of this Article]

Author Affiliations
MINNEAPOLIS; DES MOINES, IOWA

From the Division of Dermatology of the University of Minnesota, Dr. Henry E. Michelson, Director.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?